Successful exit for HTGF: LexisNexis expands its Intellectual Property Solutions suite with the acquisition of IPlytics

November 9, 2022

November 9th 2022 – LexisNexis Legal & Professional, part of RELX, today announced that it has acquired IPlytics, a leading IP intelligence company that enables the analysis of technology landscapes and competition for industries where standards and patents matter by providing access to multiple databases connecting patents, Standard Essential Patents (SEPs), standards, and technical standards contributions. The acquisition extends the vision of LexisNexis Intellectual Property Solutions to bring clarity to innovation and help companies worldwide to be more effective at bringing meaningful innovations into the world. 

Tim Pohlmann, Founder and CEO of IPlytics, says: “It is with great enthusiasm that we join forces with LexisNexis Intellectual Property Solutions. When we began discussions with LexisNexis, we immediately saw the huge potential to jointly drive innovation. At our core, we want to transform the future of market intelligence through better data and analytics and radically change how companies interact with business-critical information. This collaboration allows us to realize this vision.”

Tobias Schulz, Principal at HTGF, comments: “It is great to see that the IPlytics GmbH, with its Patent Analytics software, was acquired by the RELX Group and can expand further under the roof of its subsidiary LexisNexis in the future. As an early backer of IPlytics, it was impressive to track how the software convinced customers around the world, straight out of Berlin.”

Markus Kreßmann, Partner at HTGF, adds: “IPlytics, with its market intelligence platform for analysing patents, industry alliances and standards, was a perfect fit with HTGF’s DNA right away. The team around Dr Tim Pohlmann has taken a great development in the last years and the acquisition by RELX is now the next logical step to scale the product worldwide.”

More

 
Tobias Schulz – Principal / Authorized Signatory
 
Markus Kreßmann – Partner

Stay up to date

Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!

Press
8. October 2024

Lymphatica Medtech closes €17.9M Series B funding round to drive Innovation in Lymphedema Treatment

Lausanne, October 8th, 2024 – Lymphatica Medtech SA, a clinical-stage company based in Lausanne, Switzerland, specialized in innovative treatments for lymphedema, has raised €17.9 million in Series B funding. This investment will accelerate the clinical development and validation of LymphoDrain, a breakthrough implantable device designed to treat lymphedema, a chronic vascular condition that currently has no cure and affects millions worldwide. First of its kind, LymphoDrain is easy to i
 
Press
26. September 2024


HTGF takes a stand for diversity: Signing of the Charta der Vielfalt

Bonn, 26 September 2024 – The High-Tech Gründerfonds (HTGF), one of the leading and most active early-stage investors in Germany and Europe, signs the Charta der Vielfalt (Diversity Charter) and thus visibly commits itself to a respectful and prejudice-free working environment, both towards its employees and within the start-up ecosystem. The Diversity Charter is an initiative to promote diversity in companies and institutions under the patronage of German Chancellor Olaf Schol